Barreleye is a global leader in quantitative ultrasound solutions within the medical technology sector. The company specializes in providing diagnostic assistance solutions that analyze ultrasound signals to quantify cellular characteristics. These solutions leverage artificial intelligence to assist in real-time tissue and biomechanical analysis for breast and cardiac applications.

[Mission] Beyond Ultrasound: Seeing the Unseen
Our mission is to explore all the possibilities offered by ultrasound,
innovating in medical services and setting new standards. Our technology will contribute to healthier lives for more people in the wider world.

[Vision] Quality healthcare for all, leaving no one behind
We will transcend technological limitations and the boundaries of medical inequality, providing healthcare services accessible to everyone, anywhere,
enabling humanity to lead a meaningful life through health.

* Int-BUS : Breast Ultrasound Cancer Diagnosis AI Solution
By analyzing the biomechanical characteristics of lesions, we provide data on the probability of benign or malignant probabilities, thereby supporting early breast cancer diagnosis.

* Int-HUS : Fatty Liver Diagnosis AI Solution
Through the precise measurement of hepatic fat proportion data obtained by analyzing the biomechanical characteristics of liver tissue, we provide the ability for early detection of fatty liver and objective follow-up monitoring for diagnosis.
"Ensuring high accuracy and consistent results comparable to MRI levels."

* Vis-CUS : Echocardiography Myocardial Function Assessment AI Solution
Through AI-based analysis of cardiac ultrasound images, Vis-CUS extracts and visualizes quantitative cardiac function data, enhancing workflows and providing deep insights for diagnosis.

Barreleye

Org chart

Teams

Offices